Latest stories on ARCT
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
StockTitan50 · neutralgeneral
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
Stocktwits News58 · neutralgeneral
Arcturus Gets Citi Upgrade After Positive Liver Disease Study Data – But BTIG Says Therapy’s Benefit Is Hard To Measure
Stocktwits News61 · neutralanalyst
Arcturus raised to Buy at Citi after mid-stage trial data for liver disease drug
Seeking Alpha61 · neutralanalyst
Arcturus (ARCT) spotlights Phase 2 OTC data as LUNAR 2.0 shows 40-fold NHP expression gains
September 24, 2026
MarketChameleon67 · bullishproduct/pr
Cantor Fitzgerald reiterates Arcturus stock rating on OTCD data
Investing.com Analyst Ratings56 · neutralanalyst
Arcturus Therapeutics price target lowered to $20 from $23 at BTIG
The Fly38 · neutralanalyst
Arcturus Therapeutics upgraded to Buy from Neutral at Citi
The Fly61 · neutralanalyst
Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
Seeking Alpha67 · bullishproduct/pr
Arcturus Therapeutics to acquire myNEO
The Fly62 · neutralm&a
Arcturus Agrees to Buy myNEO, Reports Interim Liver Disorder Data
MarketWatch63 · neutralm&a
Arcturus Therapeutics Holdings Inc. (ARCT) files 8-K
SEC 8-K50 · neutralgeneral
Arcturus Therapeutics management to meet virtually with Cantor
The Fly55 · neutralgeneral
Arcturus Therapeutics: A Speculative Buy For Their OTC Deficiency Program
Seeking Alpha58 · neutralproduct/pr
Arcturus Therapeutics Holdings Inc. (ARCT) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha56 · neutralgeneral
Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital
The Fly63 · neutralanalyst
Why is Arcturus Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Arcturus, Moderna fall after BioNTech's cancer vaccine setback
Seeking Alpha34 · bearishgeneral
Arcturus Therapeutics Highlights ARCT-810 Progress at Metabolic Symposium
TipRanks63 · neutralproduct/pr